257 related articles for article (PubMed ID: 31071368)
1. Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice.
Nishio T; Hu R; Koyama Y; Liang S; Rosenthal SB; Yamamoto G; Karin D; Baglieri J; Ma HY; Xu J; Liu X; Dhar D; Iwaisako K; Taura K; Brenner DA; Kisseleva T
J Hepatol; 2019 Sep; 71(3):573-585. PubMed ID: 31071368
[TBL] [Abstract][Full Text] [Related]
2. Characterization of hepatic stellate cells, portal fibroblasts, and mesothelial cells in normal and fibrotic livers.
Lua I; Li Y; Zagory JA; Wang KS; French SW; Sévigny J; Asahina K
J Hepatol; 2016 May; 64(5):1137-1146. PubMed ID: 26806818
[TBL] [Abstract][Full Text] [Related]
3. Origin of myofibroblasts in the fibrotic liver in mice.
Iwaisako K; Jiang C; Zhang M; Cong M; Moore-Morris TJ; Park TJ; Liu X; Xu J; Wang P; Paik YH; Meng F; Asagiri M; Murray LA; Hofmann AF; Iida T; Glass CK; Brenner DA; Kisseleva T
Proc Natl Acad Sci U S A; 2014 Aug; 111(32):E3297-305. PubMed ID: 25074909
[TBL] [Abstract][Full Text] [Related]
4. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
[TBL] [Abstract][Full Text] [Related]
5. The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis.
Karin D; Koyama Y; Brenner D; Kisseleva T
Differentiation; 2016 Sep; 92(3):84-92. PubMed ID: 27591095
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin extra domain-A promotes hepatic stellate cell motility but not differentiation into myofibroblasts.
Olsen AL; Sackey BK; Marcinkiewicz C; Boettiger D; Wells RG
Gastroenterology; 2012 Apr; 142(4):928-937.e3. PubMed ID: 22202457
[TBL] [Abstract][Full Text] [Related]
7. Blockade of neutrophil extracellular trap components ameliorates cholestatic liver disease in Mdr2 (Abcb4) knockout mice.
Hintermann E; Tondello C; Fuchs S; Bayer M; Pfeilschifter JM; Taubert R; Mollenhauer M; Elferink RPJO; Manns MP; Christen U
J Autoimmun; 2024 Jun; 146():103229. PubMed ID: 38653165
[TBL] [Abstract][Full Text] [Related]
8. Knockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2
Zhou T; Wu N; Meng F; Venter J; Giang TK; Francis H; Kyritsi K; Wu C; Franchitto A; Alvaro D; Marzioni M; Onori P; Mancinelli R; Gaudio E; Glaser S; Alpini G
Lab Invest; 2018 Nov; 98(11):1449-1464. PubMed ID: 29977037
[TBL] [Abstract][Full Text] [Related]
9. NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.
Sancho P; Mainez J; Crosas-Molist E; Roncero C; Fernández-Rodriguez CM; Pinedo F; Huber H; Eferl R; Mikulits W; Fabregat I
PLoS One; 2012; 7(9):e45285. PubMed ID: 23049784
[TBL] [Abstract][Full Text] [Related]
10. Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.
Tedesco D; Thapa M; Chin CY; Ge Y; Gong M; Li J; Gumber S; Speck P; Elrod EJ; Burd EM; Kitchens WH; Magliocca JF; Adams AB; Weiss DS; Mohamadzadeh M; Grakoui A
Gastroenterology; 2018 Jun; 154(8):2178-2193. PubMed ID: 29454797
[TBL] [Abstract][Full Text] [Related]
11. Hepatic NFAT signaling regulates the expression of inflammatory cytokines in cholestasis.
Cai SY; Yu D; Soroka CJ; Wang J; Boyer JL
J Hepatol; 2021 Mar; 74(3):550-559. PubMed ID: 33039404
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation.
Lan T; Kisseleva T; Brenner DA
PLoS One; 2015; 10(7):e0129743. PubMed ID: 26222337
[TBL] [Abstract][Full Text] [Related]
13. Single-Cell Transcriptomic Analysis Reveals a Hepatic Stellate Cell-Activation Roadmap and Myofibroblast Origin During Liver Fibrosis in Mice.
Yang W; He H; Wang T; Su N; Zhang F; Jiang K; Zhu J; Zhang C; Niu K; Wang L; Yuan X; Liu N; Li L; Wei W; Hu J
Hepatology; 2021 Nov; 74(5):2774-2790. PubMed ID: 34089528
[TBL] [Abstract][Full Text] [Related]
14. Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent.
Aoyama T; Paik YH; Watanabe S; Laleu B; Gaggini F; Fioraso-Cartier L; Molango S; Heitz F; Merlot C; Szyndralewiez C; Page P; Brenner DA
Hepatology; 2012 Dec; 56(6):2316-27. PubMed ID: 22806357
[TBL] [Abstract][Full Text] [Related]
15. Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis.
Liu R; Li X; Zhu W; Wang Y; Zhao D; Wang X; Gurley EC; Liang G; Chen W; Lai G; Pandak WM; Robert Lippman H; Bajaj JS; Hylemon PB; Zhou H
Hepatology; 2019 Oct; 70(4):1317-1335. PubMed ID: 30985008
[TBL] [Abstract][Full Text] [Related]
16. Selective Inhibition of Hepatic Stellate Cell and Fibroblast-derived LOXL1 Attenuates BDL and Mdr2
Yan X; Zhang N; Wei L; Zhang W; Huang T; Li W; Chen W; Yang A; You H
Am J Physiol Gastrointest Liver Physiol; 2023 Oct; ():. PubMed ID: 37873581
[TBL] [Abstract][Full Text] [Related]
17. Liver repair and regeneration after ischemia-reperfusion injury is associated with prolonged fibrosis.
Konishi T; Schuster RM; Lentsch AB
Am J Physiol Gastrointest Liver Physiol; 2019 Mar; 316(3):G323-G331. PubMed ID: 30543462
[TBL] [Abstract][Full Text] [Related]
18. Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice.
Yoshida S; Ikenaga N; Liu SB; Peng ZW; Chung J; Sverdlov DY; Miyamoto M; Kim YO; Ogawa S; Arch RH; Schuppan D; Popov Y
Gastroenterology; 2014 Dec; 147(6):1378-92. PubMed ID: 25173753
[TBL] [Abstract][Full Text] [Related]
19. TGF-β2 silencing to target biliary-derived liver diseases.
Dropmann A; Dooley S; Dewidar B; Hammad S; Dediulia T; Werle J; Hartwig V; Ghafoory S; Woelfl S; Korhonen H; Janicot M; Wosikowski K; Itzel T; Teufel A; Schuppan D; Stojanovic A; Cerwenka A; Nittka S; Piiper A; Gaiser T; Beraza N; Milkiewicz M; Milkiewicz P; Brain JG; Jones DEJ; Weiss TS; Zanger UM; Ebert M; Meindl-Beinker NM
Gut; 2020 Sep; 69(9):1677-1690. PubMed ID: 31992593
[TBL] [Abstract][Full Text] [Related]
20. Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo.
Jiang JX; Chen X; Serizawa N; Szyndralewiez C; Page P; Schröder K; Brandes RP; Devaraj S; Török NJ
Free Radic Biol Med; 2012 Jul; 53(2):289-96. PubMed ID: 22618020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
